SmartTRAK experts across orthopedics, sports medicine, spine and enabling technology attended this year’s 2024 Canaccord Genuity Musculoskeletal and American Academy of Orthopedic Surgeons (AAOS) annual conferences. Held from February 12-15 in San Francisco, CA, these gatherings brought together the top minds in the industry. In this post, we share some key insights and updates gleaned from these conferences, offering a glimpse into the latest trends and innovations shaping the future of orthopedic and musculoskeletal care.

• MARKET

Maxx Orthopedics*
SmartTRAK learned at AAOS 2024 that Maxx Medical is going on the offensive to grow its joint replacement business in the US and that the Company plans to launch new hip and knee products in 2024.

Paragon 28*
At AAOS 2024, Paragon 28 noted that its supply chain issues have resolved and does not expect a headwind this year. As a result, Needham believes the company can return to ~20% revenue growth in 2024.

restor3d*
Restor3d reported it currently has 157 active distribution partners calling on ~22,965 orthopedic surgeons and ~18,000 podiatrists. Management noted surgeons will bring difficult cases and from there restor3d can create additional sales opportunities. CG 2024 Musculoskeletal Conference

• REVENUES

BONESUPPORT*
BONESUPPORT highlighted the continued strength of Cerament G in North America with approximate revenues of $17.0MM in Q323 since launching in June 2023. CG 2024 Musculoskeletal Conference

OrthAlign*
At AAOS 2024, SmartTRAK learned that OrthAlign’s 2023 revenue was up +25% to $51MM, led by strong adoption of its Lantern next-generation handheld navigation system and increasing use of the Balance gap balancing feature on Lantern Knee. The company noted +37% growth in the ASC setting.

Continued strength in ortho robotics placements and a crowd of new product launches in Q123 set the stage for growth in the remainder of the year.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Ortho Enabling Tech Market Recap* are:

• Complete Q123 Otho Enabling Tech Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All US Ortho Enabling Tech Companies' News, Revenues, Data, Charts and Market Shares
• Robust Q123 Robotics Performances by Company
  
  • Stryker
  • Zimmer Biomet
  • Smith+Nephew
  • JNJ/Depuy Synthes
• New Product Introductions
  
  • Robotics and Ecosystem Launches
  • Navigation and Planning Innovations
• SmartTRAK's Selected Highlights from Q123 Conferences
  
  • JP Morgan 41st Annual Healthcare Conference
  • Canaccord Genuity 2023 Musculoskeletal Conference
  • AAOS 2023 Annual Meeting

In an International Society for Technology in Arthroplasty (ISTA) presentation at the American Academy of Orthopaedic Surgeons 2023 (AAOS 2023) Annual Meeting, President, Digital, Robotics and Enabling Technology at SYK Robert Cohen discussed innovations including a fully connected operating room for a common user experience with planning and mixed-reality guidance combined with robotics and data transfer capabilities. Enabling technology continues to see adoption and integration in orthopedics and with it, the introduction of ...

Read the entire Q123 Ortho Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

More than just robots. Targeting enabling technologies to the ASC setting, development of novel assistive technologies, next-generation software updates, new applications and data insights abound at AAOS 2023.

In the US Markets for Spine and Orthopedic Enabling Technologies, it’s clear that companies are rapidly innovating and designing next-generation technologies that continue to advance the market well beyond the robotic surgical arms and platforms developed in the last decade. At this year’s American Academy of Orthopaedic Surgeons’ (AAOS) Annual Meeting, enabling technology was a big focus both on the podium and the exhibit floor. The Canaccord Genuity (CG) Musculoskeletal Conference also included a number of presentations from companies with innovative enabling technologies, including Enovis, OnPoint Surgical, THINK Surgical, OrthAlign, Augmedics, Canary Medical and newcomer Caira. Additionally, several companies on the AAOS exhibit floor were showcasing new developments across surgical planning, navigation, augmented reality, robotics and smart implants. In this Perspective article, SmartTRAK focuses in on several of the aforementioned companies, exciting technologies and important topics, including:

• These Are Not Your Father’s Robots: They're Here to Stay
• ASC Shift Driving Smaller, More Cost-Effective Solutions
• Dream Becoming Reality: Augmented Reality Competition Heats Up
• More Than Just Data: Smart Implants Show Promise in Improving Post-op Recovery
• Enabling Technology Space Continues to Grow
• Physician Adoption

With a lot of new developments expected later this year and over the next 24-48 months, the enabling technology space continues to grow and physician adoption is ...

To download and read the complete and unedited "Beyond Robotics: Enabling Tech Innovations at AAOS 2023" article by Elise Wolf, GM & VP, SmartTRAK Orthopedics, Digital & Quality, just click the button below.

SmartTRAK identifies three orthopedic robotics companies strategically positioned to shake things up this year in the fast-growing robotic-assisted TJA market.

SmartTRAK projects robotic-assisted total knee arthroplasties (TKAs) will account for 48.5% of all US TKAs and 79.6% of all US robotic-assisted joint replacements by 2026E. This growth of robotic-assisted ortho procedures and ongoing adoption of enabling tech continues to drive the US ortho robotics market. In this Market Outlook Article, SmartTRAK identifies and analyzes three robotics companies that may shake things up in 2023 and beyond. They are:

• Stryker: Racing Towards New Indications in 2023
  • On the heels of a record-breaking quarter in Q422 in terms of MAKO installations in the US and internationally, market-leader Stryker (SYK) announced in its Q422 earnings call highly-anticipated timelines for the Company’s plans to launch ...
    
• THINK Surgical: Pursuing Two New Robots in 2023
  • THINK Surgical has a different approach compared to most robotics competitors. The Company focuses on providing robotic systems for joint replacement surgery, with an open implant library as an alternative to closed systems limited to a single manufacturer's implants. At the Canaccord Genuity Healthcare Conference in 2022, the Company revealed plans to ...
    
• Globus Medical: Bringing Knee Enabling Tech to Market in 2023
  • Since Globus Medical (GMED) acquired Stelkast in 2019 as a foundation for expanding into the total joint market, an orthopedic robotic system from the Company has been looming on the horizon. In the last two years, GMED has been consistently submitting intellectual property applications related to ...
    

To read the complete "Three Ortho Robotics Companies to Watch in 2023" Market Outlook article by By Shelly Caruso, SmartTRAK's Market Analyst/Medical Writer, Just click the button below.

Q122 proved to be a mixed-bag of ups and downs with supply chain issues and Covid surges having varying impacts on market leaders’ performance amidst a strong wave of enabling tech product launches.

The Q122 WW CAS Ortho Market was down according to SmartTRAK Financial Dashboard. Stryker* remained the market leader, followed by Zimmer Biomet* and Smith & Nephew*. For detailed Q122 revenues and shares by company in the US, EU and ROW, see the SmartTRAK CAS Ortho Financial Dashboard.

Among the many topics covered in detail in our comprehensive Q122 CAS Ortho Market Recap* are: